Modest outcomes from pharmacogenomic (PGx) testing in depression may be influenced by low rates of actionable gene-drug interactions. This 12-week pilot pragmatic randomized clinical trial evaluated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results